A Review of Telehealth Innovations for HIV Pre-Exposure Prophylaxis (PrEP)

Curr HIV/AIDS Rep. 2019 Feb;16(1):113-119. doi: 10.1007/s11904-019-00430-z.

Abstract

Purpose of review: This review summarizes novel interventions that employ technology to improve HIV pre-exposure prophylaxis (PrEP) availability, uptake, and adherence.

Recent findings: Several notable technology-based programs are increasing access to PrEP in unique ways. We identified multiple models for using telehealth to bolster PrEP dissemination and adherence, such as mobile applications that offer PrEP prescribing without an in-person visit, longitudinal distance telementoring for community provider PrEP education and clinical guidance, and electronic consults for PrEP specialist support in the primary care setting. Outcomes data for all of these modalities are limited but show promise. Technology-based interventions can address gaps in the PrEP care continuum. Future research should assess and compare outcomes, scalability, cost-effectiveness, and sustainability. Costs associated with the creation of new technological tools slow innovation and the field would benefit from a platform for technology sharing.

Keywords: HIV prevention; Pre-exposure prophylaxis; Technology; Telehealth.

Publication types

  • Review

MeSH terms

  • Anti-HIV Agents / therapeutic use
  • Continuity of Patient Care
  • Cost-Benefit Analysis
  • Emtricitabine / therapeutic use
  • HIV Infections / drug therapy
  • HIV Infections / prevention & control*
  • Humans
  • Male
  • Mobile Applications*
  • Pre-Exposure Prophylaxis / economics
  • Pre-Exposure Prophylaxis / methods*
  • Primary Health Care
  • Telemedicine / economics
  • Telemedicine / methods*
  • Tenofovir / therapeutic use

Substances

  • Anti-HIV Agents
  • Tenofovir
  • Emtricitabine